MedPath

Effect of Tub Bathing on Skin and Bilirubin Levels in Infants Undergoing Tunnel and LED of Phototherapy

Not Applicable
Completed
Conditions
Newborn Jaundice
Interventions
Other: TUBE BATH
Registration Number
NCT04962113
Lead Sponsor
Istanbul University - Cerrahpasa (IUC)
Brief Summary

The study was conducted as a randomized controlled study to determine effect of tube bathing on skin and bilirubin levels in infants undergoing tunnel and LED of phototherapy. The population of the study consisted of term babies with the diagnosis of hyperbilirubinemia in Gaziantep Cengiz Gökçek Maternity and Pediatrics Hospital and Kilis State Hospital Neonatal Intensive Care Units (NICU) among November 2019-September 2020. The sample size was composed of a total of 140 babies, which were determined according to Power Analysis and met the case selection criteria. Accordingly, Thirty-five babies were randomly assigned to each group (Tunnel Group = experiment and control; LED Group = experiment and control). The babies in the experimental groups were given a tube bath at 6 and 12 hours after phototherapy started. On the other hand, the babies in the control groups were given routine cares in the units. Data were gathered 'Information and Registration Form', Neonatal Skin Risk Assessment Scale (NSRAS) and Neonatal Skin Condition Score (NSCS).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
140
Inclusion Criteria
  • The baby is receiving phototherapy due to physiological hyperbilirubinemia,
  • Being a term newborn,
  • Monitoring of the LED group in the incubator and the tunnel group in the tunnel phototherapy device,
  • Parents' consent to participate in the study.
Exclusion Criteria
  • Rh incompatibility between mother and baby,
  • Finding ABO non-compliance,
  • Positive direct Coombs test,
  • Presence of congenital anomaly or syndrome,
  • Any surgical intervention has been or will be made,
  • Having any skin lesions,
  • The need for mechanical ventilation.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
LED group Tube bath during the phototherapyTUBE BATH-
Tunnel group Tube bath during the phototherapyTUBE BATH-
Primary Outcome Measures
NameTimeMethod
Sample size1-2 month

The sample size was composed of a total of 140 babies, which were determined according to Power Analysis and met the case selection criteria.

Divided groups1 month

Thirty-five babies were randomly assigned to each group (Tunnel Group = experiment and control; LED Group = experiment and control).

Experiment difining and time12 month

The babies in the experimental groups were given a tube bath at 6 and 12 hours after phototherapy started. On the other hand, the babies in the control groups were given routine cares in the units.

MeasurementFirst, 6-12-24 hours for each nerwborn

Data were gathered 'Information and Registration Form', Neonatal Skin Risk Assessment Scale (NSRAS) and Neonatal Skin Condition Score (NSCS).

Biochemical measurementFirst, 6-12-24 hours for each nerwborn

Total serum bilirubin values obtained from patient files.

TSB Findings10 month

When differences regarding decrease in 24-hour total serum bilirubin (TSB) levels were compared in all relevant experimental groups, statistically differences were observed (p˂ .001). In particular, the levels of bilirubin were listed as LED-trial, Tunnel-trial, Tunnel-control and LED-control, respectively. It is worthy to utter herein that the decline in TSB was more notable in bathing groups.

Skin care findings10 month

Skin integrity and moisture balance were better in bathing groups than control groups, the best was in the Tunnel-experimental group and the worst was in the Tunnel-control group (p˂ .001).

Conclusion12 month

Tube bath is suggested that decreasing total serum bilirubin level and maintaining skin integrity and moisture balance.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Serap ÖZDEMİR

🇹🇷

Gaziantep, Turkey

© Copyright 2025. All Rights Reserved by MedPath